Literature DB >> 19572147

Splicing variants of the orphan G-protein-coupled receptor GPR56 regulate the activity of transcription factors associated with tumorigenesis.

Jeong-Eun Kim1, Ji Man Han, Cho Rong Park, Kum-Joo Shin, Curie Ahn, Jae Young Seong, Jong-Ik Hwang.   

Abstract

PURPOSE: GPR56 is an orphan G-protein-coupled receptor of the adhesion family involved in brain development. In some cancer cells and tissues, GPR56 is highly expressed and may contribute to tumorigenesis phenotypes such as cell adhesion and metastasis. Although the ligand for GPR56 is unknown, the overexpression of the receptor induces the activity of several transcription factors. We identified Wve splicing forms of GPR56 by searching the genome database. In this study, we tried to assess the properties of the splicing variants on the activation of the transcription factors.
METHODS: Genome structure of human GPR56 genes was analyzed using the Ensembl genome browser. All splicing variants were constructed using PCR with the GPR56 wildtype gene as template and the appropriate primers and their expression was verified by western blotting. We examined the effect of GPR56 splicing forms on the cellular responses through reporter gene assay with various promoters. We also confirmed the GPR56-mediated transcriptional activity by silencing GPR56 expression through shRNA-mediated RNA interference.
RESULTS: We found that the coding sequence of GPR56 consist of 13 exons and alternative splicing occurs in the second and tenth exons. In reporter gene assays, GPR56 overexpression increased the activity of the serum-response element, NFAT, and E2F response elements, whereas this overexpression downregulated c-myc and p53 response element activity. Furthermore, increased promoter activity of the COX2, iNOS, and VEGF genes was observed. Variants 1 and 2 potently enhanced SRE-mediated transcription compared with wild-type GPR56. Variants 3 and 4 hardly aVect the activity of the promoters.
CONCLUSION: These results suggested that the splicing of GPR56 may induce differential tumorigenic responses owing to their varied ability to activate transcription factors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19572147     DOI: 10.1007/s00432-009-0635-z

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  22 in total

Review 1.  The ETS-domain transcription factor family.

Authors:  A D Sharrocks
Journal:  Nat Rev Mol Cell Biol       Date:  2001-11       Impact factor: 94.444

2.  GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis.

Authors:  Lei Xu; Shahinoor Begum; Jeremy D Hearn; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-06       Impact factor: 11.205

Review 3.  The p53 pathway: positive and negative feedback loops.

Authors:  Sandra L Harris; Arnold J Levine
Journal:  Oncogene       Date:  2005-04-18       Impact factor: 9.867

Review 4.  E2F - at the crossroads of life and death.

Authors:  Shirley Polager; Doron Ginsberg
Journal:  Trends Cell Biol       Date:  2008-09-18       Impact factor: 20.808

Review 5.  The many faces of G protein signaling.

Authors:  H E Hamm
Journal:  J Biol Chem       Date:  1998-01-09       Impact factor: 5.157

Review 6.  Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis.

Authors:  E Fosslien
Journal:  Ann Clin Lab Sci       Date:  2001-10       Impact factor: 1.256

7.  A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis.

Authors:  H Nishimori; T Shiratsuchi; T Urano; Y Kimura; K Kiyono; K Tatsumi; S Yoshida; M Ono; M Kuwano; Y Nakamura; T Tokino
Journal:  Oncogene       Date:  1997-10       Impact factor: 9.867

8.  Chemokine production by G protein-coupled receptor activation in a human mast cell line: roles of extracellular signal-regulated kinase and NFAT.

Authors:  H Ali; J Ahamed; C Hernandez-Munain; J L Baron; M S Krangel; D D Patel
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

9.  Disease-associated mutations affect GPR56 protein trafficking and cell surface expression.

Authors:  Zhaohui Jin; Ian Tietjen; Lihong Bu; Liqun Liu-Yesucevitz; Shantanu K Gaur; Christopher A Walsh; Xianhua Piao
Journal:  Hum Mol Genet       Date:  2007-06-18       Impact factor: 6.150

10.  Individual cell-based models of tumor-environment interactions: Multiple effects of CD97 on tumor invasion.

Authors:  Joerg Galle; Doreen Sittig; Isabelle Hanisch; Manja Wobus; Elke Wandel; Markus Loeffler; Gabriela Aust
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

View more
  17 in total

1.  mRNA isoform diversity can obscure detection of miRNA-mediated control of translation.

Authors:  Jennifer L Clancy; Grace H Wei; Nicole Echner; David T Humphreys; Traude H Beilharz; Thomas Preiss
Journal:  RNA       Date:  2011-04-05       Impact factor: 4.942

Review 2.  Function of alternative splicing.

Authors:  Olga Kelemen; Paolo Convertini; Zhaiyi Zhang; Yuan Wen; Manli Shen; Marina Falaleeva; Stefan Stamm
Journal:  Gene       Date:  2012-08-15       Impact factor: 3.688

Review 3.  Adhesion G protein-coupled receptors: signaling, pharmacology, and mechanisms of activation.

Authors:  Kevin J Paavola; Randy A Hall
Journal:  Mol Pharmacol       Date:  2012-07-20       Impact factor: 4.436

4.  A splicing isoform of GPR56 mediates microglial synaptic refinement via phosphatidylserine binding.

Authors:  Tao Li; Brian Chiou; Casey K Gilman; Rong Luo; Tatsuhiro Koshi; Diankun Yu; Hayeon C Oak; Stefanie Giera; Erin Johnson-Venkatesh; Allie K Muthukumar; Beth Stevens; Hisashi Umemori; Xianhua Piao
Journal:  EMBO J       Date:  2020-05-25       Impact factor: 11.598

5.  Overlap of polymicrogyria, hydrocephalus, and Joubert syndrome in a family with novel truncating mutations in ADGRG1/GPR56 and KIAA0556.

Authors:  Edmund S Cauley; Ahlam Hamed; Inaam N Mohamed; Maha Elseed; Samantha Martinez; Ashraf Yahia; Fatima Abozar; Rayan Abubakr; Mahmoud Koko; Liena Elsayed; Xianhua Piao; Mustafa A Salih; M Chiara Manzini
Journal:  Neurogenetics       Date:  2019-04-13       Impact factor: 2.660

Review 6.  Adhesion G Protein-Coupled Receptors as Drug Targets for Neurological Diseases.

Authors:  Christopher J Folts; Stefanie Giera; Tao Li; Xianhua Piao
Journal:  Trends Pharmacol Sci       Date:  2019-03-11       Impact factor: 14.819

7.  Structural Basis for Regulation of GPR56/ADGRG1 by Its Alternatively Spliced Extracellular Domains.

Authors:  Gabriel S Salzman; Sarah D Ackerman; Chen Ding; Akiko Koide; Katherine Leon; Rong Luo; Hannah M Stoveken; Celia G Fernandez; Gregory G Tall; Xianhua Piao; Kelly R Monk; Shohei Koide; Demet Araç
Journal:  Neuron       Date:  2016-09-21       Impact factor: 17.173

8.  G-protein coupled receptor 56 promotes myoblast fusion through serum response factor- and nuclear factor of activated T-cell-mediated signalling but is not essential for muscle development in vivo.

Authors:  Melissa P Wu; Jamie R Doyle; Brenda Barry; Ariane Beauvais; Anete Rozkalne; Xianhua Piao; Michael W Lawlor; Alan S Kopin; Christopher A Walsh; Emanuela Gussoni
Journal:  FEBS J       Date:  2013-10-08       Impact factor: 5.542

9.  Dihydromunduletone Is a Small-Molecule Selective Adhesion G Protein-Coupled Receptor Antagonist.

Authors:  Hannah M Stoveken; Laura L Bahr; M W Anders; Andrew P Wojtovich; Alan V Smrcka; Gregory G Tall
Journal:  Mol Pharmacol       Date:  2016-06-23       Impact factor: 4.436

10.  Transcriptomic and phospho-proteomic analyzes of erythroblasts expanded in vitro from normal donors and from patients with polycythemia vera.

Authors:  Todd Hricik; Giulia Federici; Ann Zeuner; Giuliana Alimena; Agostino Tafuri; Valentina Tirelli; Lilian Varricchio; Francesca Masiello; Fiorella Ciaffoni; Stefania Vaglio; Emanuel F Petricoin; Gabriella Girelli; Ross L Levine; Anna Rita F Migliaccio
Journal:  Am J Hematol       Date:  2013-07-03       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.